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In Aggregatibacter actinomycetemcomitans, different serotypes have been described based on LPS antigenicity. Recently, our research group has reported a differential 
immunogenicity when T lymphocytes were stimulated with these different serotypes. In 
particular, it was demonstrated that the serotype b of A. actinomycetemcomitans has a 
stronger capacity to trigger Th1- and Th17-type cytokine production. Objective: This study 
aimed to quantify the expression of different CC chemokines (CCLs) and receptors (CCRs) in T 
lymphocytes stimulated with the different A. actinomycetemcomitans serotypes. In addition, 
the expression of the transcription factors T-bet, GATA-3, RORC2, and Foxp3, master-switch 
genes implied in the Th1, Th2, Th17, and T-regulatory differentiation, respectively, was 
analysed in order to determine T-cell phenotype-speci¿c patterns of CCL and CCR expression 
upon A. actinomycetemcomitans stimulation. Material and Methods: Human naïve CD4+ T 
lymphocytes were obtained from healthy subjects and stimulated with autologous dendritic 
cells primed with the different A. actinomycetemcomitans serotypes. The expression levels 
for the chemokines CCL1, CCL2, CCL3, CCL5, CCL11, CCL17, CCL20, CCL21, CCL25, and 
CCL28, as well as the chemokine receptors CCR1, CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, 
CCR8, CCR, and CCR10 were quanti¿ed by qPCR. Similarly, the expression levels for the 
transcription factors T-bet, GATA-3, RORC2, and Foxp3 were quanti¿ed and correlated 
with the CCL and CCR expression levels. Results: Higher expression levels of CCL2, CCL3, 
CCL5, CCL20, CCL21, CCL28, CCR1, CCR2, CCR5, CCR6, CCR7, and CCR9 were detected 
in T lymphocytes stimulated with the serotype b of A. actinomycetemcomitans compared 
with the other serotypes. In addition, these higher expression levels of CCLs and CCRs 
positively correlated with the increased levels of T-bet and RORC2 when T lymphocytes 
were stimulated with the serotype b. Conclusion: A T-lymphocyte response biased towards 
a Th1- and Th17-pattern of CCL and CCR expression was detected under stimulation with 
the serotype b of A. actinomycetemcomitans.
Keywords: Aggregatibacter actinomycetemcomitans. Chemokines. Chemokine receptors. 
T-lymphocytes. Th1 cells. Th17 cells.
INTRODUCTION
In humans, CC chemokines (CCLs) and their 
speci¿c CC receptors (CCRs) play a central role 
in physiological and pathological recruitment 
of immune cells9,24. During infectious diseases, 
the expression of CCLs and CCRs produces a 
chemotactic gradient between regional lymph 
nodes and infected tissues where, depending 
on the pattern of CCLs and/or CCRs expressed, 
specific dendritic cells and T lymphocytes are 
chemoattracted. Thus, it is established a cellular 
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pathway that goes both ways, in which 1) dendritic 
cells migrate toward lymphoid organs to present 
microbial antigens and 2) activated T helper (Th) 
lymphocytes migrate toward infected tissues to 
accomplish their speci¿c immunological function24.
Th lymphocytes play a central role in the 
pathogenesis of periodontitis, and a Th1 and Th17-
dominated immuno-inÀammatory response has 
been associated with periodontal tissue destruction, 
alveolar bone resorption, and teeth loss. In this 
context, the pattern of CCLs and CCRs expressed 
by Th lymphocytes is crucial in the establishment 
of the local Th-pattern of immuno-inÀammatory 
response and in the outcome of the disease9,28. In 
fact, greater levels of CCL3, CCL4, CCL5, CCL28, 
CCR1, CCR5, and CCR9 were detected in periodontal 
lesions of aggressive periodontitis patients, and 
increased levels of CCL2 and CCR4 were found 
in lesions of chronic periodontitis patients8,23. In 
addition, increased production of IF1-Ǆ has been 
associated with both greater expression of CCR5 
and differentiation of Th1 lymphocytes16. Similarly, 
increased production of IL-6 and IL-23 has been 
associated with both greater expression of CCL2, 
CCR6, and CCR7, and subsequent differentiation, 
migration, and activation of Th17 lymphocytes13,15. 
Conversely, increased production of IL-4 and IL-10 
has been demonstrated to inhibit the production 
of CCR5 and to induce the expression of CCL11, 
CCR3, and CCR4, implied in the Th2 lymphocyte 
differentiation and function18.
 Recently, our research group has reported a 
differential immunogenicity when dendritic cells and 
T lymphocytes were stimulated with the different 
serotypes of A. actinomycetemcomitans2,3. In 
particular, when T lymphocytes were stimulated with 
autologous monocyte-derived dendritic cells primed 
with the serotype b of A. actinomycetemcomitans, 
higher levels of Th1- and Th17-associated 
transcription factors and cytokines were detected 
compared with similar experiments with the other 
serotypes, demonstrating that serotype b strains 
of A. actinomycetemcomitans have a higher 
capacity of triggering Th1 and Th17 phenotype 
and function. It is, therefore, the aim of this 
investigation to elucidate whether the different 
serotypes of A. actinomycetemcomitans have 
a role on the differential expression of CCLs 
and CCRs. We hypothesized that the serotype 
b of A. actinomycetemcomitans, when used to 
stimulate T lymphocytes, induces higher Th1- and 
Th17-associated CCL and CCR expression when 
compared with the other A. actinomycetemcomitans 
serotypes.
MATERIAL AND METHODS
Experimental design
This experimental study consisted of cell cultures 
of peripheral naïve CD4+ T lymphocytes obtained 
from healthy humans and infected in vitro with A. 
actinomycetemcomitans. The protocol of the study 
was clearly explained to all the participants, who 
agreed to participate in it by signing an institutional 
review board-approved informed consent (Protocol 
2010/14). The study was conducted in accordance 
with the Helsinki Declaration of 1975, as revised 
in 2000.
A. actinomycetemcomitans strains
The A. actinomycetemcomitans strains ATCC® 
43717™ (serotype a), ATCC® 43718™ (serotype 
b), and ATCC® 43719™ (serotype c) were cultured 
on agar brain-heart infusion medium (Oxoid, 
Hampshire, UK) at 37°C and under capnophilic 
conditions (8% O2 and 12% CO2) using an 
appropriate microaerobic condition generator 
(CampyGen™; Oxoid, Hampshire, UK). Growth 
curves were obtained, and live bacteria, having their 
whole antigenic potentiality, were obtained at the 
exponential growth phase of the bacterial culture 
and used for in vitro cell stimulation.
Blood donors
Blood cells were obtained during platelet-
apheresis process from healthy donors consecutively 
enrolled at the Blood Bank of the Hospital Del 
Salvador in the Eastern Metropolitan Health Service. 
The study group consisted of 12 adult individuals 
(seven males and ¿ve females, aged 21 to 38 years, 
mean age of 28.3±5.10 years) who did not have 
periodontal disease as determined by absence of 
gingival inÀammation, clinical attachment loss, 
or increased probing depths (PD>3 mm). Further 
exclusion criteria were the positive test for HIV 
and hepatitis B or C virus, presence of manifest 
infections during the last month, fever, symptomatic 
allergies, abnormal blood cell counts, increased liver 
enzymes, or medication of any kind except vitamins 
and oral contraceptives.
Monocyte-derived dendritic cell generation
For each subject, peripheral blood mononuclear 
cells (PBMCs) were isolated by density gradient 
centrifugation using standard procedures (Ficoll-
Paque Plus; GE Healthcare, Uppsala, Sweden). 
For generating a puri¿ed population of immature 
dendritic cells, monocytes were purified from 
PBMCs by magnetic cell sorting separation (MACS; 
Miltenyi Biotec, Bergisch Gladbach, Germany). 
BrieÀy, PBMCs were incubated with an anti-CD14 
monoclonal antibody conjugated to magnetic 
beads for 15 min at 4°C, loaded onto LS columns 
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and then separated in the magnetic ¿eld of a 
cell separator (MACS; Miltenyi Biotec, Bergisch 
Gladbach, Germany). The retained CD14+ cells, 
which correspond to monocytes, were then Àushed 
out and washed twice in phosphate-buffered saline. 
Monocytes were then immediately differentiated to 
dendritic cell by culturing at 106 cells/mL in RPMI-
1640 medium supplemented with 10% fetal calf 
serum (Gibco Invitrogen Corp., Grand Island, NY, 
USA) and 20 ng/mL rhGM-CSF and rhIL-4 (R&D 
Systems Inc., Minneapolis, MN, USA) for 6 d at 
37°C.
T-lympKocyte pXri¿cation
A puri¿ed population of naïve CD4+ T lymphocytes 
was obtained from PBMCs by magnetic cell sorting 
depletion (MACS; Miltenyi Biotec, Bergisch 
Gladbach, Germany). BrieÀy, both non-T helper 
and memory T helper cells were depleted using a 
cocktail of biotin-conjugated monoclonal antibodies 
(CD8, CD14, CD15, CD16, CD19, CD25, CD34, 
CD36, CD45RO, CD56, CD123, TCRǄ/į, HLA-DR, 
and CD235a) and anti-biotin monoclonal antibodies 
conjugated to magnetic beads. The magnetically 
labelled cells were retained within LD columns in the 
magnetic ¿eld of a cell separator (MACS; Miltenyi 
Biotec, Bergisch Gladbach, Germany), while the 
unlabelled naïve CD4+ T lymphocytes ran through.
Cell stimulation
Monocyte-derived dendrit ic cel ls were 
primed at a multiplicity of infection MOI=102 
(bacteria/cells ratio) with different serotypes 
of A. actinomycetemcomitans, and then 106 
T-lymphocytes/mL were activated with primed 
autologous dendritic cells (50:1) in culture with 
RPMI-1640 containing 10% foetal calf serum 
(Gibco Invitrogen Corp., Grand Island, NY, USA) 
for 5 d at 37°C. Previous to each cell co-culture, 
dendritic cells were washed twice with RPMI-1640 
supplemented with 50 IU/mL penicillin and 50 ǋg/
mL streptomycin (Sigma Chemical Co., St. Louis, 
MI, USA). T-lymphocyte cultures devoid of dendritic 
cells or exposed to non-induced autologous 
dendritic cells were used for comparisons. In each 
experimental step, dendritic cell and T-lymphocyte 
counting was performed with a hemocytometer and 
using a phase contrast microscopy (Axiovert 100; 
Zeiss Co., Göttingen, Germany), and cell viability 
equal to or higher than 95% was calculated by 
Trypan blue dye exclusion. For each individual, the 
experiment was performed separately.
Phenotypic cell analysis
T-lymphocyte puri¿cation and their subsequent 
activation were analyzed by Àow cytometry (BD 
FACSCanto™; Becton Dickinson Immunocytometry 
Systems, San José, CA, USA). Cells were stained using 
the following monoclonal antibodies conjugated with 
Àuorescein isothiocyanate (FITC) or phycoerythrin 
(PE): anti-CD4 (CD4+ T-lymphocytes), anti-CD25Į 
(activated CD4+ T-lymphocytes), anti-CD45RA 
(naïve CD4+ T-lymphocytes), and anti-CD45RO 
(memory CD4+ T-lymphocytes) following the 
manufacturer’s recommendations (BD Biosciences 
Pharmingen, San José, CA, USA). Isotype-matched 
control monoclonal antibodies were used to 
determine the negative cell populations.
Expression of CD25D, CCR, CCL, and 
transcription factor mRNAs
From activated T lymphocytes, total cytoplasmic 
RNA was isolated using 400 μl of ice-cold lysis buffer 
containing 0.5% Igepal® CA-630 (Sigma-Aldrich, 
Saint Louis, MO, USA), 50 mM Tris-HCl pH8, 100 
mM NaCl, 5 mM MgCl2, and 10 mM VRC-40 (Gibco 
Invitrogen, Carlsbad, CA, USA). Isolated RNA was 
quanti¿ed using a spectrophotometer (Synergy 
HT; Bio-Tek Instrument Inc., Winooski, VT, USA), 
and the ¿rst-strand cDNA was synthesized using 
5 μg of total RNA with a SuperScrip™III reverse 
transcription kit, following the manufacturer’s 
instructions (Invitrogen, Grand Island, NY, USA). 
The mRNA expression levels for the chemokines 
CCL1, CCL2, CCL3, CCL5, CCL11, CCL17, CCL20, 
CCL21, CCL25, and CCL28, the chemokine receptors 
CCR1, CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, 
CCR8, CCR9, and CCR10 and the transcription 
factors T-bet (Th1), GATA-3 (Th2), RORC2 
(Th17), and Foxp3 (T-regulatory), as well as for 
the activated T-lymphocyte marker CD25D, were 
quanti¿ed by qPCR using the appropriate primers 
(Figure 1). BrieÀy, 50 ng of cDNA were ampli¿ed 
using a KAPA™ SYBR® Fast qPCR reagent (KAPA 
Biosystems, Woburn, MA, USA) in a StepOnePlus® 
equipment (Applied Biosystems, Singapore) as 
follows: 95°C for 3 min, followed by 40 cycles of 
95°C for 3 s, and 60°C for 30 s, and ¿nally a melt 
curve of 95°C for 15 s, 60°C for 1 min, and 95°C 
for 15 s, for detection of non-speci¿c product 
formation and false positive ampli¿cation. As an 
endogenous control, 18S rRNA expression levels 
were determined.
Data analysis
The Àow cytometry data were analyzed using 
the WinMDi 2.9 software (The Scripps Research 
Institute, La Jolla, CA, USA), represented as 
histograms, and expressed as the percentage 
of positive cells over the total. The qPCR data 
were analyzed using the StepOne Software 2.2.2 
(Applied Biosystems, Singapore) and presented in 
fold-change of relative quantities by normalizing 
the CD25D, CCR, CCL, or transcription factor 
mRNA expression to 18S rRNA expression using 
the 2-ƩƩCt method. Data were statistically analyzed 
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using the SPSS 15.0 software (Lead Technologies 
Inc., Charlotte, NC, USA). The normality of data 
distribution was determined using the Kolmogorov-
Smirnov test. Differences regarding CD expression 
levels analyzed by Àow cytometry were determined 
using the chi-square test. Differences among groups 
and within each group regarding the CD25D, CCR, 
CCL, and transcription factor mRNA expression were 
analyzed using the Kruskal-Wallis test or ANOVA 
and Tukey post-hoc tests. Correlation coef¿cients 
were obtained using the Pearson or Spearman 
tests. Asterisks were used to graphically indicate 
statistical signi¿cance. A value of p0.05 was 
considered statistically signi¿cant.
RESULTS
T-lymphocyte puri¿cation and activation
For this study, highly puri¿ed (>98%) populations 
of naïve CD4+ T lymphocytes (CD4+CD25Į -
CD45RA+CD45RO-), devoid of activated or memory 
CD4+ T lymphocytes, were isolated from peripheral 
blood of healthy donors (Figure 2A). These T 
lymphocytes activated at a similar extent upon 
stimulation with dendritic cells primed with the 
different serotypes of A. actinomycetemcomitans, 
as shown by the similar signi¿cant overexpression 
in CD25D mRNA levels (p<0.001) compared with T 
lymphocytes exposed to non-induced dendritic cells 
(Figure 2B). These similar levels of T lymphocyte 
activation were con¿rmed at a protein level when the 
cell-surface expression of CD25D was determined 
by Àow cytometry. In fact, the frequency of CD25D 
expression (~15%) in T lymphocytes exposed to the 
different serotypes of A. actinomycetemcomitans 
did not differ signi¿cantly (Figure 2C).
E x p r e s s i o n  o f  C C L s  b y  A . 
act inomycetemcomitans- induced T 
lymphocytes
The mRNA expression for the analyzed chemokines 
was determined by qPCR and represented as fold-
mRNA Forward Primer Reverse Primer
CD25D caagcgagccttccagatt ggccactgctacctggtact
CCL1 ttgctgctagctgggatgt ctggagaagggtacctgcat
CCL2 gcctccagcatgaaagtctc ggaatgaaggtggctgctat
CCL3 cagcagacagtggtcagtcc ttctgagcaggtgacggaat
CCL5 ggtgtggtgtccgaggaata cctcattgctactgccctct
CCL11 cccttcagcgactagagagc cagctttctggggacatttg
CCL17 ggcttctctgcagcacatc ggaatggctcccttgaagta
CCL20 gctgctttgatgtcagtgct gcagtcaaagttgcttgctg
CCL21 caccctctaccacagacatgg aggccagaaccaggataagg
CCL25 ctgagttggtcctccctctg aatcaggccaactccctctt
CCL28 ccacctacctggttcaaacg cgggctgacacagattcttc
CCR1 agtacctgcggcagttgttc aaggggagccatttaaccag
CCR2 tttctgataaaccgagaacgaga gagacaagccacaagctgaa
CCR3 gagtgtgtggccagaagaca cttcctggattcagccctct
CCR4 accgcgtgcacaattgc tttacagtggcatattctttgtcatg
CCR5 gaccagccccaagatgacta cttgggtggtggctgtgt
CCR6 tcagccccttcagctcac actgtggctgttggtttgtg
CCR7 ttggtttaggggacaatagcc ggctgataagctaacaccagaca
CCR8 atgcctagggagagctgtga aaaatgtagtctacgctggagga
CCR9 tttccccagacactgagagc tgttaggaatagggcttgtgg
CCR10 agtaggtgggggaacactga gcaaggcacagaggtagtcc
T-bet tccaagtttaatcagcaccaga tgacaggaatgggaacatcc
GATA-3 ctcattaagcccaagcgaag tctgacagttcgcacaggac
RORC2 agaaggacagggagccaag caagggatcacttcaatttgtg
Foxp3 acctacgccacgctcatc tcattgagtgtccgctgct
18S rRNA ctcaacacgggaaacctcac cgctccaccaactaagaacg
Figure 1- )RUZDUG DQG UHYHUVH SULPHUV XVHG IRU &'Į &&/ &&5 DQG WUDQVFULSWLRQ IDFWRU P51$ DQG 6 U51$
DPSOL¿FDWLRQVE\T3&5
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change for each condition (Figure 3). When the 
strain ATCC® 43718™ belonging to the serotype 
b of A. actinomycetemcomitans was used for 
T-lymphocyte activation, higher expression levels 
of CCL2 (p=0.025 and p=0.024), CCL3 (p=0.003 
and p=0.005), CCL5 (p=0.004 and p=0.013), 
CCL20 (p=0.05 and p=0.02), CCL21 (p=0.001 
and p=0.001), and CCL28 (p=0.004 and p=0.008) 
were detected, when compared with the strains 
ATCC® 43717™ and ATCC® 43719™ belonging to 
the serotypes a or c, respectively. Conversely, when 
the serotype a of A. actinomycetemcomitans was 
used for T-lymphocyte activation, higher expression 
levels of CCL1 (p=0.008 and p=0.009) and CCL17 
(p>0.05 and p>0.05) were detected, when 
compared with the serotypes b or c, respectively. 
CCL11 and CCL25 were not over-expressed in any 
experimental condition.
E x p r e s s i o n  C C R s  b y  A . 
act inomycetemcomitans- induced T 
lymphocytes
The mRNA expression for the analyzed chemokine 
receptors was determined by qPCR and represented 
as fold-change for each condition (Figure 4). When 
the serotype b of A. actinomycetemcomitans was 
Figure 2-7O\PSKRF\WHSXUL¿FDWLRQDQGDFWLYDWLRQ$7O\PSKRF\WHSXUL¿FDWLRQ)ORZF\WRPHWU\DQDO\VLVRI&'&'D, 
CD45RA, and CD45RO expression demonstrating the purity of naïve CD4+ T lymphocytes isolated from healthy donors. 
B: T-lymphocyte activation. The qPCR analysis for the CD25D mRNA expression in CD4+ T lymphocytes stimulated by 
autologous dendritic cells primed at a MOI=102 with the A. actinomycetemcomitans strains ATCC® 43717™ (serotype a), 
ATCC® 43718™ (serotype b), and ATCC® 43719™ (serotype c). C: T-lymphocyte activation. Flow cytometry analysis of 
the CD25D expression demonstrating the levels of activation of CD4+ T lymphocytes after 5-day stimulation under the 
VDPHFRQGLWLRQVGHVFULEHGLQ)LJXUH%7KHÀRZF\WRPHWU\GDWDIURPHDFKH[SHULPHQWZHUHH[SUHVVHGDVSHUFHQWDJH
of positive cells over the total, and shown as mean±SD from 4 independent experiments. For relative expression, the 
CD25D mRNA expression in T lymphocytes cultured in the absence of dendritic cells was considered as 1, as a reference 
for fold-change in expression. Data are represented as fold-change for 8 independent experiments. Each experiment was 
SHUIRUPHGLQGXSOLFDWH&RPSDULVRQVZHUHGRQHYHUVXV7O\PSKRF\WHVH[SRVHGWRQRQLQGXFHGGHQGULWLFFHOOVS
Aa, Aggregatibacter actinomycetemcomitans; CD, cluster of differentiation; DCs, dendritic cells
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used for T-lymphocyte activation, higher expression 
levels of CCR1 (p=0.036 and p=0.026), CCR2 
(p=0.041 and p=0.042), CCR5 (p=0.029 and 
p=0.035), CCR6 (p=0.045 and p=0.044), CCR7 
(p=0.039 and p=0.020), CCR9 (p=0.040 and 
p=0.035), and CCR10 (p=0.018 and p=0.022) 
were detected compared with the serotypes a or 
c, respectively. Conversely, when the serotype 
a of A. actinomycetemcomitans was used for 
T-lymphocyte activation, higher expression levels 
of CCR3 (p=0.006 and p=0.007), CCR4 (p>0.05 
and p>0.05), and CCR8 (p>0.05 and p>0.05) were 
detected, when compared with the serotypes b or 
c, respectively.
Expression of T-bet, GATA-3, RORC2, and 
Foxp3 by A. actinomycetemcomitans-
induced T lymphocytes
The mRNA expression for T-bet, GATA-3, 
RORC2, and Foxp3 was determined by qPCR in T 
lymphocytes stimulated by dendritic cells primed 
at a MOI=102 with the different serotypes of A. 
actinomycetemcomitans (Figure 5). Similarly to our 
previous experiments2, T lymphocytes stimulated 
with the serotype b showed a higher relative 
expression of T-bet (p<0.001 and p<0.001) and 
RORC2 (p<0.001 and p=0.001) mRNAs than the 
same cells stimulated with the serotypes a or c, 
respectively.
Correlation analysis between T-bet, GATA-
3, RORC2, and Foxp3 versus CCL and CCR 
expression levels
The correlation analyses between the expression 
of the transcription factors and the CCLs and CCRs 
on each activation condition tested (Table 1) yielded 
positive correlation between T-bet and CCL2, CCL3, 
CCL5, CCL25, CCR1, CCR2, CCR5, and CCR9, 
being statistically signi¿cant for CCL5 (p=0.049), 
CCR1 (p=0.040), and CCR2 (p=0.046), when T 
lymphocytes were stimulated with the serotype 
b of A. actinomycetemcomitans. Under the same 
Figure 3- CC chemokines (CCL) expression by A. actinomycetemcomitans-induced T lymphocytes. CCL mRNA expression 
in T lymphocytes activated by dendritic cells primed at a MOI=102 with the A. actinomycetemcomitans strains ATCC® 
43717™ (serotype a), ATCC® 43718™ (serotype b), and ATCC® 43719™ (serotype c). For relative expression, the CCL 
mRNA expression in T lymphocytes exposed to non-induced dendritic cells was considered as 1, as a reference for fold-
change in expression (n.i). Data are represented as fold-change for 8 independent experiments. Each experiment was 
performed in duplicate. Comparisons were done between the different A. actinomycetemcomitansVHURW\SHVS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condition, a positive correlation was also observed 
between RORC2 and CCL20, CCL21, CCR6, and 
CCR7, being statistically significant for CCL20 
(p=0.041), CCL21 (p=0.004), and CCR7 (p=0.030). 
In contrast, GATA-3 showed positive correlation 
with CCL1, CCL17, CCR3, CCR4, and CCR8, being 
statistically signi¿cant for CCL1 (p=0.049), CCL17 
(p=0.046), CCR4 (p=0.002), and CCR8 (p=0.048) 
when T lymphocytes were stimulated with the 
serotype a of A. actinomycetemcomitans and 
with CCR8 (p=0.044) when the same cells were 
stimulated with the serotype c. Foxp3 did not show 
positive correlation with any CCL or CCR (data not 
shown). Overall, a T-lymphocyte response biased 
towards a Th1- and Th17-pattern of CCL and CCR 
expression was detected under stimulation with the 
serotype b of A. actinomycetemcomitans.
DISCUSSION
There is strong evidence suggesting that 
variations in the host immuno-inflammatory 
response, in particular, in the T lymphocyte 
phenotype and function, play an important role in the 
susceptibility, onset, and severity of periodontitis6,10. 
In particular, a Th1 and Th17-dominated immuno-
inÀammatory response has been associated with 
the pathogenesis of periodontitis, and an increased 
expression of Th1- and Th17-related transcription 
factors and pro-inÀammatory mediators have been 
reported in active periodontal lesions, where alveolar 
bone resorption is occurring6,17. In this study, the 
expression levels of different CCLs and CCRs were 
analyzed in human naïve T lymphocytes, stimulated 
with dendritic cells primed with different serotypes 
of A. actinomycetemcomitans, demonstrating that 
the serotype b induced greater expression levels 
of Th1- and Th17-associated CCLs and CCRs, when 
compared with the other serotypes.
The association between the serotype b of A. 
actinomycetemcomitans and the pathogenesis of the 
periodontitis has been previously analyzed2,3,27,30,32. 
In fact, the serotype b of A. actinomycetemcomitans 
triggers a greater immunogenic and pathogenic 
Figure 4- CC receptors (CCR) expression by A. actinomycetemcomitans-induced T lymphocytes. CCR mRNA expression 
in T lymphocytes activated by dendritic cells primed at a MOI=102 with the A. actinomycetemcomitans strains ATCC® 
43717™ (serotype a), ATCC® 43718™ (serotype b), and ATCC® 43719™ (serotype c). For relative expression, the CCR 
mRNA expression in T lymphocytes exposed to non-induced dendritic cells was considered as 1, as a reference for fold-
change in expression (n.i). Data are represented as fold-change for 8 independent experiments. Each experiment was 
performed in duplicate. Comparisons were done between the different A. actinomycetemcomitansVHURW\SHVS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Aggregatibacter actinomycetemcomitans
Serotype a Serotype b Serotype c
r p-value r p-value r p-value
T-bet CCL2 -0.606 0.394 0.918 0.082 -0.487 0.513
CCL3 -0.755 0.245 0.882 0.118 -0.799 0.201
CCL5 -0.485 0.515 0.931 0.049* -0.682 0.318
CCL25 0.585 0.415 0.909 0.091 0.800 0.200
CCR1 -0.250 0.750 0.956 0.040* 0.522 0.478
CCR2 -0.800 0.200 0.934 0.046* -0.762 0.238
CCR5 -0.745 0.255 0.882 0.118 -0.966 0.004
CCR9 -0.971 0.029 0.896 0.104 -0.711 0.289
GATA-3 CCL1 0.920 0.049* 0.837 0.063 0.130 0.870
CCL11 -0.125 0.825 0.912 0.088 -0.178 0.822
CCL17 0.934 0.046* 0.519 0.481 -0.072 0.928
CCL28 -0.231 0.769 0.304 0.696 0.251 0.749
CCR3 0.880 0.120 0.628 0.372 0.620 0.380
CCR4 0.998 0.002* -0.020 0.980 0.578 0.422
CCR8 0.932 0.048* 0.940 0.060 0.956 0.044*
CCR10 0.162 0.838 -0.878 0.122 0.144 0.856
RORC2 CCL20 0.897 0.103 0.939 0.041* 0.357 0.643
CCL21 0.403 0.597 0.996 0.004* -0.229 0.771
CCR6 -0.852 0.148 0.875 0.125 -0.717 0.283
CCR7 0.998 0.002* 0.970 0.030* 0.909 0.091
Table 1- Correlation analysis of transcription factors versus CCL and CCR mRNA expressions. The Pearson’s correlation 
FRHI¿FLHQW UEHWZHHQ WKH WUDQVFULSWLRQ IDFWRUV7EHW 7K*$7$ 7KDQG525&7KDQG WKH7K7KRU
Th17-associated CCLs and CCRs were calculated using T lymphocytes stimulated by autologous dendritic cells primed at 
a MOI=102 with the different A. actinomycetemcomitansVHURW\SHVS
Figure 5- Transcription factor expression by A. actinomycetemcomitans-induced T lymphocytes. T-bet (Th1), GATA-3 
(Th2), RORC2 (Th17), and Foxp3 (T-regulatory) mRNA expression in T lymphocytes stimulated by dendritic cells primed 
at a MOI=102 with the A. actinomycetemcomitans strains ATCC® 43717™ (serotype a), ATCC® 43718™ (serotype b), 
and ATCC® 43719™ (serotype c). For relative expression, the transcription factor mRNA expression in T lymphocytes 
exposed to non-induced dendritic cells was considered as 1, as a reference for fold-change in expression (n.i.). Data are 
represented as fold-change for 8 independent experiments. Each experiment was performed in duplicate. Comparisons 
were done between the different A. actinomycetemcomitansVHURW\SHVS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response when in contact with different host cells 
compared with the other serotypes. For instance, 
the serotype b induces increased resistance to 
phagocytosis and to killing by macrophages and 
neutrophils32, higher expression of IL-8 and ICAM-1 
in gingival epithelial cells27, greater production of 
IL-1ǃ in macrophages30, and stronger induction of 
Th1- and Th17-type of response in dendritic cells 
and CD4+ T lymphocytes2,3.
To our knowledge, this is the first report 
associating the different serotypes of A. 
actinomycetemcomitans with a Th1- and Th17-
pattern of immuno-inflammatory response by 
analyzing the CC chemokines and receptors 
involved in the selective chemo-attraction of Th 
lymphocytes. These ¿ndings are suggestive of the 
pathogenic role of A. actinomycetemcomitans in 
the aetiology of periodontitis, which may differ 
among serotypes and speci¿cally let us propose that 
serotype b could play a role in the pathogenesis of 
the disease by the induction of a local inÀammatory 
environment that favors the speci¿c recruitment of 
Th1 and Th17 lymphocytes towards the infected 
periodontal tissues.
In rheumatoid arthritis, which is an inÀammatory 
disease characterized by the development of a 
Th1 and Th17-dominated immuno-inÀammatory 
response in the affected articular tissues14, it 
has been established that the chronicity of the 
inÀammation is associated with a Th1- and Th17-
pattern of CCL and CCR expression. In fact, in chronic 
inÀamed joints, over-expressed levels of CCL2, 
CCL3, CCL5, CCR1, CCR2, and CCR5, related to a 
Th1-type response26,29, and CCL20, CCL21, CCR6, 
and CCR7, related to a Th17-type response14,22, 
have been detected compared with non-inÀamed 
joints. In addition, increased expression of CCL20 
has been associated with predominant Th17 
lymphocyte in¿ltration in the affected articular 
tissues11 and, when the chemokine receptors CCR1, 
CCR2, CCR5, and CCR6 were blocked, a decreased 
Th1 lymphocyte migration towards the inÀamed 
joints was detected, promoting the resolution of 
the disease11,26.
The results of the present study are consistent 
with the available scientific evidence, and 
demonstrate that a Th1- and Th17-pattern of 
immuno-inÀammatory response develops during 
the periodontal infection, at least during an in vitro 
mono-infection with A. actinomycetemcomitans. 
Thus, the Th1 and Th17-dominated immuno-
inÀammatory response described in periodontitis 
could be explained by the increased chemo-
attraction of recently activated and differentiated 
Th1 and Th17 lymphocytes from regional lymph 
nodes and/or by the activation of naïve and 
memory Th1 and Th17 lymphocytes residing in the 
periodontal tissues12,25. In this context, the serotype 
b of A. actinomycetemcomitans could be associated 
with local periodontal tissue destruction by the over-
production of Th1- and Th17-associated cytokines, 
such as IL1-ǃ, IL-6, IL-17A, and TNF-D2,3, and the 
over-expression of Th1- and Th17-associated CCLs 
and CCRs, such as CCL2, CCL3, CCL5, CCR1, CCR2, 
CCR5, and CCR7, as demonstrated in the present 
study, which are involved in the differentiation 
and activation of osteoclasts and the resorption 
of tooth-supporting alveolar bone6-9,28. In fact, 
a more frequent and higher expression of CCL2 
and its speci¿c receptor CCR4 have been reported 
in chronic periodontitis, and a more prevalent 
and higher expression of CCL3 and its speci¿c 
receptor CCR5 have been reported in aggressive 
periodontitis9. Thus, the A. actinomycetemcomitans 
serotype b-induced Th1 and/or Th17 lymphocytes 
could migrate towards infected tissues following the 
CCL2 and/or CCL3 chemotactic gradient, resulting in 
a Th1 and/or Th17-associated cytokine production 
at the periodontal lesion that locally promote the 
alveolar bone resorption.
The A. actinomycetemcomitans strains used 
in the present study are phenotypically smooth. 
In fact, these different serotypes correspond to 
structurally distinct O-polysaccharide components 
of their respective LPS that function as immuno-
dominant antigens. The O-polysaccharide from 
the LPS produced by the serotype b of A. 
actinomycetemcomitans is structurally distinct 
from the O-polysaccharide produced by the other 
serotypes. In particular, the O-polysaccharide from 
serotype b consists of a repeating trisaccharide 
unit composed of D-D-fucose, D-L-rhamnose 
and ǃ-D-N-acetyl-galactosamine residues, and 
the O-polysaccharide from serotypes a and c is 
composed of 6-deoxy-D-D-talose and 6-deoxy-D-
L-talose, respectively19,20.
Interestingly, our data also show that serotype 
b of A. actinomycetemcomitans induces an 
increment in the CCR10 expression in stimulated 
T lymphocytes, a chemokine receptor associated 
with Th2 lymphocyte differentiation and function31. 
In this context, it has been demonstrated that 
CCR10 is also expressed by Th22 lymphocytes, a 
recently described T lymphocyte population that 
complies pro-inÀammatory activities5; however, 
this T-cell phenotype has not yet been described in 
periodontitis. Accordingly, it could be hypothesized 
that Th22 lymphocytes may be associated with the 
pathogenesis of periodontitis1, which would clarify, 
at least to a certain degree, the over-expressed 
levels of CCR10 and its speci¿c chemokine ligand 
CCL28 detected in the present study. In fact, 
higher levels of CCL28 have been detected in the 
gingival crevicular Àuid of chronic and aggressive 
periodontitis patients compared with gingivitis and 
healthy individuals4.
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During periodontitis, antigen presentation may 
occur both in the regional lymph nodes that drain 
the periodontal tissues and locally in the infected 
periodontal tissues, in a periodontal site-speci¿c 
manner. In fact, formation of periodontal lymphoid 
clusters in which dendritic cells present bacterial 
antigens to naïve or memory T lymphocytes has been 
reported, promoting the activation and selective 
differentiation of Th1 and Th17 lymphocytes12,25. 
In this scenario, CCR7 and its speci¿c chemokine 
ligands CCL19 and CCL21 could play a role in the 
organization of these cellular clusters, as an ectopic 
lymphoid-like structure21, promoting the alveolar 
bone resorption characteristic of the periodontitis.
CONCLUSIONS
In T lymphocytes, the serotype b of A. 
actinomycetemcomitans induces higher expression 
levels of chemokines CCL2, CCL3, CCL5, CCL20, 
CCL21, and CCL28 and of chemokine receptors 
CCR1, CCR2, CCR5, CCR6, CCR7, and CCR9, 
when compared with the other serotypes. These 
increased levels associated with the expression 
of the transcription factors master-switch genes 
that trigger the Th1 and Th17 lymphocyte 
differentiation. Considered together, these data 
let us propose that variability in the Th1 and Th17 
immuno-inÀammatory response induced by the 
different serotypes of A. actinomycetemcomitans 
is associated, at least to a certain degree, with the 
CC chemokines and receptors that they express; 
however, functional studies are necessary to con¿rm 
our hypothesis.
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